Tirzepatide (CAS 2023788-19-2, molecular formula C225H348N48O68), commonly shortened to Tirz, is a synthetic dual GIP and GLP-1 receptor agonist peptide studied for its interaction with incretin receptor signalling pathways. PhaseOne has tirzepatide peptide for sale online to researchers across Australia as a high-purity lyophilised powder, independently HPLC verified at ≥99% purity per batch.
As a dual-incretin research peptide, Tirz is studied alongside related metabolic peptides such as Retatrutide within Australian peptide research, manufactured to research-grade standards and independently third-party tested for identity and consistency, with every order shipped Australia-wide. The Tirzepatide COA for every batch is published in our public lab report library.
Tirzepatide is a synthetic 39-amino-acid peptide and dual GIP/GLP-1 receptor agonist, studied within Australian peptide research for its interaction with incretin receptor signalling pathways.
Tirz is the common shorthand for Tirzepatide, and tirzepatide peptide is the same thing again. It is frequently misspelt as tirzapetide, tirzepitide, tirzepetide or tirzeptide. All refer to the same dual GIP/GLP-1 receptor agonist. PhaseOne supplies Tirz peptide in 10mg vials for laboratory research use only.
Yes. PhaseOne has Tirz peptide for sale online in 10mg vials, shipped Australia-wide. It is supplied as a lyophilised research powder, with the batch Certificate of Analysis published in our public COA library.
Semaglutide is a single-receptor GLP-1 agonist. Tirzepatide binds two receptors, GIP and GLP-1, making it a dual agonist. The receptor count is the core structural difference between the two.
PhaseOne ships tirzepatide Australia-wide for research use, dispatched locally with tracking, in 10mg vials. The Certificate of Analysis for each batch, verifying ≥99% HPLC purity, is published in our public COA library.
Orders placed before 12pm (Sydney time) on a business day are dispatched the same day from Sydney. Express delivery usually takes 1 to 3 business days, and express shipping is free on orders over $100.
PhaseOne prices tirzepatide at A$109.99 for a 10mg vial, and the batch Certificate of Analysis is free to view in our public COA library. Current pricing is shown on this page.
PhaseOne currently supplies tirzepatide in 10mg vials of lyophilised research powder.
Tirzepatide is a dual GIP/GLP-1 receptor agonist, whereas Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist; the two have distinct receptor profiles studied within metabolic peptide research. Compare them in our Retatrutide vs Tirzepatide guide, or view our Retatrutide.
Unreconstituted tirzepatide should be stored refrigerated and protected from light, and is commonly reconstituted with bacteriostatic water prior to research preparation. Read our reconstitution guide.
Each batch of tirzepatide is independently verified by third-party HPLC analysis, with the Certificate of Analysis for every batch published in our public COA library.
The Certificate of Analysis for each tirzepatide batch is published in our public lab report library, so you can check the HPLC result before you order.
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
